bioRxiv · 10.1101/2025.01.09.632263
Dimerization and dynamics of angiotensin-I converting enzyme revealed by cryoEM and MD simulations
Abstract
Angiotensin-I converting enzyme (ACE) regulates the levels of disparate bioactive peptides, notably converting angiotensin-I to angiotensin-II and degrading amyloid beta. ACE is a heavily glycosylated dimer, containing 4 analogous catalytic sites, and exists in membrane bound and soluble (sACE) forms. ACE inhibition is a frontline, FDA-approved, therapy for cardiovascular diseases yet is associated with significant side effects, including higher rates of lung cancer. To date, structural studies have been confined to individual domains or partially denatured cryo-EM structures. Here we report the cryo-EM structure of the glycosylated full sACE dimer. We resolved four structural states at 2.99 to 3.65 [A] resolution which are primarily differentiated by varying degrees of solvent accessibility to the active sites and reveal the full dimerization interface. We also employed all-atom molecular dynamics (MD) simulations and heterogeneity analysis in cryoSPARC, cryoDRGN, and RECOVAR to elucidate the conformational dynamics of sACE and identify key regions mediating conformational change. We identify differences in the mechanisms governing the conformational dynamics of individual domains that have implications for the design of domain-specific sACE modulators.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Tang, W.-J., mancl, j. M., Wu, X., Zhao, M.. 2025-01-14. Dimerization and dynamics of angiotensin-I converting enzyme revealed by cryoEM and MD simulations. https://doi.org/10.1101/2025.01.09.632263
Cite the original work for its findings. Save a collection to share your selection of sources.